Profil
Hans Nijman is the founder of ViciniVax BV, a company he founded in 2008 where he holds the title of Director-Clinical Research since 2010.
In 2008, he also started working as a Professor at the University of Groningen, where he currently holds the title.
Postes actifs de Hans Nijman
| Sociétés | Poste | Début |
|---|---|---|
ViciniVax BV
 ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | Fondateur | 01/01/2008 |
| University of Groningen | Corporate Officer/Principal | 20/04/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | Health Technology |
